Nourish, the largest dietitian-led metabolic health clinic in the U.S., has raised $100 million in a Series C led by Menlo Ventures, with participation from Thrive Capital, Index Ventures, J.P. Morgan Growth Equity Partners, Y Combinator, and others. Total funding to date is $215 million.
The company pairs over 10,000 registered dietitians with AI agents to deliver virtual metabolic care covering nutrition, GLP-1 prescribing and medication management, lab testing, and behavior change support. Nourish is available to over 200 million covered lives through partnerships with the nation’s largest health plans, health systems, and employers – typically at no cost to patients.
The clinical outcomes are notable: 8% weight loss, 1.3 point A1C reduction, 31 point LDL cholesterol reduction, and 23 point systolic blood pressure reduction, translating to over $2,000 per patient in annual cost savings for health plans. The company has completed millions of appointments and more than tripled year-over-year since founding four years ago.
“Chronic disease is the largest cost driver in U.S. healthcare, and the system still isn’t built to treat it,” said co-founder and CEO Aidan Dewar. “Too often, patients get expensive, reactive, fragmented care that doesn’t actually make them healthier. We’ve built the care model and technology to change that.”
The GLP-1 connection is particularly relevant: fewer than half of patients remain on GLP-1s at six months, and most who discontinue regain the weight without sustained nutrition and behavior support. Nourish integrates medication into a nutrition-first care model designed for long-term behavior change – an approach that intersects with the growing conversation around how GLP-1s interact with women’s hormonal health, a question that Aavia’s recent report flagged as one of the most urgent open issues in women’s metabolic health.
The funding will support clinical network growth, AI investment, metabolic clinic expansion, and deeper payer and health system partnerships.
